北海道大学大学院医学研究院 呼吸器内科学教室 北海道大学病院 呼吸器内科 Department of Respiratory Medicine, Faculty of Medicine, Hokkaido University

研究業績

業績

2021年 研究業績

原著論文
  1. Abe Y, Suzuki M, Kimura H, Shimizu K, Makita H, Nishimura M, Konno S: “Annual Fractional Exhaled Nitric Oxide Measurements and Exacerbations in Severe Asthma”, J Asthma Allergy, 13:731-741(2021) PubMedへ
  2. Abe Y, Suzuki M, Makita H, Kimura H, Shimizu K, Konno S, Nishimura M: “One-year clinically important deterioration and long-term clinical course in Japanese patients with COPD: a multicenter observational cohort study ”, BMC Pulm Med.,21(1):159(2021) PubMedへ
  3. Abe Y, Suzuki M, Shima H, Shiraishi Y, Tanabe N, Sato S, Shimizu K, Kimura H, Makita H, Hirai T, Konno S, Nishimura M: “Annual body weight change and prognosis in chronic obstructive pulmonary disease”, Int J Chron Obstruct Pulmon Dis, 16: 3243-3253(2021) PubMedへ
  4. Asahina H, Tanaka K, Morita S, Maemondo M, Seike M, Okamoto I, Oizumi S, Kagamu H, Takahashi K, Kikuchi T, Isobe T, Sugio K, Kobayashi K: “A Phase II Study of Osimertinib Combined With Platinum Plus Pemetrexed in Patients With EGFR-Mutated Advanced Non-Small-cell Lung Cancer: The OPAL Study (NEJ032C/LOGIK1801)”, Clin Lung Cancer, 22(2):147-151(2021) PubMedへ
  5. Goudarzi H, Kimura H, Makita H, Abe Y, Oguma A, Sato M, Matsumoto M, Takei N, Kimura H, Shimizu K, Suzuki M, Ito YM, Nishimura M, Konno S: “Association of abdominal visceral adiposity with sputum IL-5 levels in asthma”, Allergol Int,71(1):137-139(2021) PubMedへ
  6. Hagio K, Amano T, Hayashi H, Takeshita T, Oshino T, Kikuchi J, Ohhara Y, Yabe I, Kinoshita I, Nishihara H, Yamashita H: “Impact of clinical targeted sequencing on endocrine responsiveness in estrogen receptor-positive, HER2-negative metastatic breast cancer”, Scientific Reports,11(1):8109(2021) PubMedへ
  7. Hattori T, Saito A, Chiba H, Kuronuma K, Amishima M, Morinaga D, Shichinohe Y, Nasuhara Y, Konno S: “Characteristics of COVID-19 patients admitted into two hospitals in Sapporo, Japan: Analyses and insights from two outbreak waves.” Respir Ivest, 59(2):180-186(2021) PubMedへ
  8. Ito S, Asahina H, Honjo O, Tanaka H, Honda R, Oizumi S, Nakamura K, Takamura K, Hommura F, Kawai Y, Ito K, Sukoh N, Yokoo K, Morita R, Harada T, Takashina T, Goda T, Dosaka-Akita H, Isobe H; Hokkaido Lung Cancer Clinical Study Group Trial: “Prognostic factors in patients with advanced non-small cell lung cancer after long-term Anti-PD-1 therapy (HOT1902)”, Lung Cancer, 156:12-19(2021) PubMedへ
  9. Itoh S, Yamazaki K, Suyama S, Ikeda-Araki A, Miyashita C, Ait Bamai Y, Kobayashi S, Masuda H, Yamaguchi T, Goudarzi H, Okada E, Kashino I, Saito T Kishi R: “The association between prenatal perfluoroalkyl substance exposure and symptoms of attention-deficit/hyperactivity disorder in 8-year-old children and the mediating role of thyroid hormones in the Hokkaido study”, Environ Int,159:107026(2021) PubMedへ
  10. Izumi H , Matsumoto S , Liu J, Tanaka K, Mori S, Hayashi K, Kumagai S, Shibata Y, Hayashida T, Watanabe K, Fukuhara T, Ikeda T, Yoh K, Kato T, Nishino K, Nakamura A, Nakachi I, Kuyama S, Furuya N, Sakakibara-Konishi J, Okamoto I, Taima K, Ebi N, Daga H, Yamasaki A, Kodani M, Udagawa H, Kirita K, Zenke Y, Nosaki K, Sugiyama E, Sakai T, Nakai T, Ishii G, Niho S, Ohtsu A, Kobayashi S, Goto K: “The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung cancer”, Nature,600(7888):319-323(2021) PubMedへ
  11. Kamada K, Konno S, Kaneko T, Fukunaga K, Hasegawa Y, Yokoyama A: “The effect of the outbreak of COVID-19 on respiratory physicians and healthcare in Japan: Serial nationwide surveys by the Japanese Respiratory Society”, Respir Investig, 59(6):792-798(2021) PubMedへ
  12. Kamada K, Yoshida A, Iguchi S, Arai Y, Uzawa Y, Konno S, Shimojima M, Kikuchi K: “Geographical distribution and regional differences in 532 clinical isolates of rapidly growing mycobacterial species in Japan”, Sci Rep, 11(1):4960(2021) PubMedへ
  13. Kamada K, Yoshida A, Iguchi S, Arai Y, Uzawa Y, Konno S, Shimojima M, Kikuchi K: “Nationwide surveillance of antimicrobial susceptibility of 509 rapidly growing mycobacteria strains isolated from clinical specimens in Japan”, Sci Rep,11(1):12208(2021) PubMedへ
  14. Kikuchi J, Ohhara Y, Takada K, Tanabe H, Hatanaka K, Amano T, Hatanaka-KC,Hatanaka Y, Mitamura T, Kato M, Shibata Y, Yabe I, Endoh A, Komatsu Y, Matsuno Y, Sugiyama M, Manabe A, Sakurai A, Takahashi M, Naruse H, Torimoto Y, Dosaka-Akita H, Kinoshita I: “Clinical significance of comprehensive genomic profiling tests covered by public insurance in patients with advanced solid cancers in Hokkaido, Japan”,Jpn J Clin Oncol,51(5):753-761(2021) PubMedへ
  15. Kim HC, Suzuki M, Lim HF , Lan LTT, Nguyen HL, Wang JS, Lee KY, Lee JS, Oh YM, Lee SD, Choi H, Lee H, Lee SW: “Survey of the management of patients with bronchiectasis: a pilot investigation in Asian populations”, Korean J Intern Med, 36(6):1402-1409(2021) PubMedへ
  16. Kimura H, Makita H, Taniguchi N, Takei N, Matsumoto M, Kimura H, Goudarzi H, Shimizu K, Suzuki M, Nishimura M, Konno S, and the Hi-CARAT investigators: “Determination of the cutoff values of Th2 markers for the prediction of future exacerbation in severe asthma: An analysis from the Hokkaido Severe Asthma Cohort Study”, Allergol Int, 70(1):68-73(2021) PubMedへ
  17. Kishi R, Ikeda-Araki A, Miyashita C, Itoh S, Kobayashi S, Ait Bamai Y, Yamazaki K, Tamura N, Minatoya M, Ketema RM, Poudel K, Miura R, Masuda H, Itoh M, Goudarzi H: “Hokkaido birth cohort study on environment and children's health: cohort profile 2021”, Environ Health Prev Med, 26(1):59(2021) PubMedへ
  18. Kitazawa H, Hizawa N, Nishimura Y, Fujisawa T, Iwanaga T, Sano A, Nagase H, Matsumoto H, Horiguchi T, Konno S, Asano K: “The impact of the COVID-19 pandemic on asthma treatment in Japan: Perspectives based on doctors' views”, Respir Investig, 59(5):670-674(2021) PubMedへ
  19. Kitazawa H, Masuko H, Kanazawa J, Shigemasa R, Hyodo K, Yamada H, Yatagai Y, Kaneko Y, Iijima H, Naito T, Saito T, Noguchi E, Konno S, Hirota T, Tamari M, Sakamoto T, Hizawa N: “ORMDL3/GSDMB genotype as a risk factor for early-onset adult asthma is linked to total serum IgE levels but not to allergic sensitization”, Allergol Int, 70(1):55-60(2021) PubMedへ
  20. Kitazawa H, Masuko H, Kanazawa J, Shigemasa R, Hyodo K, Yamada H, Yatagai Y, Kaneko Y, Iijima H, Naito T, Saito T, Noguchi E, Konno S, Hirota T, Tamari M, Sakamoto T, Hizawa N: “ORMDL3/GSDMB genotype is associated with distinct phenotypes of adult asthma”, Allergol Int, 70(4):495-497(2021) PubMedへ
  21. Kobayashi S, Sata F, Goudarzi H, Araki A, Miyashita C, Sasaki S, Okada E, Iwasaki Y, Nakajima T, Kishi R: “Associations among perfluorooctanesulfonic/perfluorooctanoic acid levels, nuclear receptor gene polymorphisms, and lipid levels in pregnant women in the Hokkaido study”, Sci Rep,11(1):9994(2021) PubMedへ
  22. Kobayashi S, Sata F, Ikeda-Araki A, Miyashita C, Goudarzi H, Iwasaki Y, Nakajima T, Kishi R: “Relationships between maternal perfluoroalkyl substance levels, polymorphisms of receptor genes, and adverse birth outcomes in the Hokkaido birth cohort study, Japan”, Reprod Toxicol,107:112-122(2021) PubMedへ
  23. Kobayashi S, Sata F, Ikeda-Araki A, Miyashita C, Itoh S, Goudarzi H, Iwasaki Y, Mitsui T, Moriya K, Shinohara N, Cho K, Kishi R: “Associations among maternal perfluoroalkyl substance levels, fetal sex-hormone enzymatic gene polymorphisms, and fetal sex hormone levels in the Hokkaido study”, Reprod Toxicol, 105:221-231(2021) PubMedへ
  24. Kobayashi Y, Sato T, Nagai T, Hirata K, Tsuneta S, Kato Y, Komoriyama H, Kamiya K, Konishi T, Omote K, Ohira H, Kudo K, Konno S, Anzai T: “Association of high serum soluble interleukin 2 receptor levels with risk of adverse events in cardiac sarcoidosis”, ESC Heart Fail,8(6):5282-5292(2021) PubMedへ
  25. Matsumoto-Sasaki M, Simizu K, Suzuki M, Suzuki M, Kimura H, Nakamaru Y, Ito YM, Honma A, Konno S: “Clinical Characteristics of Patients and Factors Associated with Switching Biologics in Asthma”, J Asthma Allergy, 15:187-195(2021) PubMedへ
  26. Mimori T, Shukuya T, Ko R, Okuma Y, Koizumi T, Imai H, Takiguchi Y, Miyauchi E, Kagamu H, Sugiyama T, Azuma K, Namba Y, Yamasaki M, Tanaka H, Takashima Y, Soda S, Ishimoto O, Koyama N, Kobayashi K, Takahashi K: “Clinical Significance of Tumor Markers for Advanced Thymic Carcinoma: A Retrospective Analysis from the NEJ023 Study”, Cancers (Basel), 2021 in press PubMedへ
  27. Muro S, Suzuki M, Nakamura S, Wang JR, Garry EM, Sakamoto W, de Souza S: “Real-world effectiveness of early intervention with fixed-dose tiotropium/olodaterol vs tiotropium in Japanese patients with COPD: a high-dimensional propensity score-matched cohort analysis”, Respir Res, 22(1):180(2021) PubMedへ
  28. Nagase H, Nishimura Y, Matsumoto H, Sugimoto N, Iwanaga T, Sano A, Konno S, Hizawa N, Asano K, Horiguchi T, Yokoyama A; Japanese Respiratory Society, Scientific Assembly for Allergy, Immunology, and Inflammation: “The prevalence of comorbid respiratory disease among COVID-19 patients, and mortality during the first wave in Japan: A nationwide survey by the Japanese Respiratory Society”, Respir Investig, 59(5):679-682（2021） PubMedへ
  29. Ninagawa K, Kato M, Ohira H, Tsuneta S, Iwano H, Kono M, Fujieda Y, Oku K, Tsujino I, Atsumi T: “The assessment of left heart disease in patients with systemic sclerosis and pulmonary hypertension”, Clin Exp Rheumatol,131(4):103-110(2021) PubMedへ
  30. Ogo T, Shimokawahara H, Kinoshita H, Sakao S, Abe K, Matoba S, Motoki H, Takama N, Ako J, Ikeda Y, Joho S, Maki H, Saeki T, Sugano T, Tsujino I, Yoshioka K, Shiota N, Tanaka S, Yamamoto C, Tanabe N, Tatsumi K,Study Group: “Selexipag for the treatment of chronic thromboembolic pulmonary hypertension”, Eur Respir J, 2101694(2021) PubMedへ
  31. Oguri S, Fujisawa S, Kamada K, Nakakubo S, Yamashita Y, Nakamura J, Horii H, Sato K, Nishida M, Teshima T, Ohiro Y, Takada A, Konno S: “Effect of varying storage conditions on diagnostic test outcomes of SARSCoV-2”, J Infect, 83(1):119-145(2021) PubMedへ
  32. Ohara A, Konno S, Shimizu K, Suzuki M, Yamamoto M, Mitani A, Nishida M, Teshima T, Nishimura M: “Two cases of chronic obstructive pulmonary disease with undetectable diffusing capacity for carbon monoxide”, Respir Investig, 59(1):145-148(2021)PubMedへ
  33. Saito Y, Takekuma Y, Kobayashi M, Shinagawa N, Shimizu Y, Kinoshita I, Dosaka-Akita H, Iseki K, Sugawara M: “Impact of histamine type-2 receptor antagonists on the anticancer efficacy of gefitinib in patients with non-small cell lung cancer”, Eur J Clin Pharmacol, 77(3):381-388(2021) PubMedへ
  34. Sakai H, Morise M, Kato T, Matsumoto S, Sakamoto T, Kumagai T, Tokito T, Atagi S, Kozuki T, Tanaka H, Chikamori K, Shinagawa N, Takeoka H, Bruns R, Straub J, Schumacher KM, Paik PK: “Tepotinib in patients with NSCLC harbouring MET exon 14 skipping: Japanese subset analysis from the Phase II VISION study”, Jpn J Clin Oncol,51(8): 1261-1268（2021） PubMedへ
  35. Sakamoto N, Sawahata M, Yamanouchi Y, Konno S, Shijubo N, Yamaguchi T, Nakamura Y, Suzuki T, Hagiwara K, Bando M: “Characteristics of patients with a diagnosis of sarcoidosis: Comparison of the 2006 and 2015 versions of diagnostic criteria for sarcoidosis in Japan”, J Rural Med, 16(2):77-82(2021) PubMedへ
  36. Sakaue S, Yamaguchi E, Inoue Y, Takahashi M, Hirata J, Suzuki K, Ito S, Arai T, Hirose M, Tanino Y, Nikaido T, Ichiwata T, Ohkouchi S, Hirano T, Takada T, Miyawaki S, Dofuku S, Maeda Y, Nii T, Kishikawa T, Ogawa K, Masuda T, Yamamoto K, Sonehara K, Tazawa R, Morimoto K, Takaki M, Konno S, Suzuki M, Tomii K, Nakagawa A, Handa T, Tanizawa K, Ishii H, Ishida M, Kato T, Takeda N, Yokomura K, Matsui T, Watanabe M, Inoue H, Imaizumi K, Goto Y, Kida H, Fujisawa T, Suda T, Yamada T, Satake Y, Ibata H, Hizawa N, Mochizuki H, Kumanogoh A, Matsuda F, Nakata K, Hirota T, Tamari M, Okada Y: “Genetic determinants of risk in autoimmune pulmonary alveolar proteinosis”, Nat Commun, 12(1):1032(2021) PubMedへ
  37. Sato T, Ambale-Venkatesh B, Zimmerman SL, Tedford RJ, Hsu S, Chamera E, Fujii T, Mullin CJ, Mercurio V, Khair R, Corona-Villalobos CP, Simpson CE, Damico RL, Kolb TM, Mathai SC, Lima JAC, Kass DA, Tsujino I, Hassoun PM: “ Right ventricular function as assessed by cardiac magnetic resonance imaging-derived strain parameters compared to high-fidelity micromanometer catheter measurements”, Pulm Circ, 11(4):20458940211032529(2021) PubMedへ
  38. Sawahata M, Johkoh T, Kawanobe T, Kono C, Suzuki T, Bando M, Hagiwara K, Shijubo N, Konno S, Yamaguchi T: “Paradoxical Formation of a Pleuroparenchymal Fibroelastosis-like Lesion in the Chronic Course of Pulmonary Sarcoidosis”, Intern Med, 61(4):523-526(2021) PubMedへ
  39. Sawahata M, Shijubo N, Johkoh T, Kawanobe T, Fujiki Y, Bando M, Hagiwara K, Takemura T, Konno S, Yamaguchi T: “Progression of Central-peripheral Band and Traction Bronchiectasis Clusters Leading to Chronic Respiratory Failure in a Patient with Fibrotic Pulmonary Sarcoidosis”, Intern Med, 60(1):111-116(2021) PubMedへ
  40. Shiiya H, Ujiie H, Hida Y, Kato T, Kaga K, Wakasa S, Kikuchi E, Shinagawa N, Okada K, Ito YM, Matsuno Y: “Elevated serum CYFRA 21-1 level as a diagnostic marker for thymic carcinoma”, Thorac Cancer , 12(21): 2933-2942(2021) PubMedへ
  41. Shimizu K, Tanabe N, Oguma A, Kimura H, Suzuki M, Yokota I, Makita H, Sato S, Hirai T, Nishimura M, Konno S, Hi-CARAT investigators: “Parenchymal destruction in asthma: Fixed airflow obstruction and lung function trajectory”, J Allergy Clin Immunol, 149(3):934-942(2021) PubMedへ
  42. Shimura T, Abe K, Takenouchi T, Yamada M, Suzuki H, Suematsu M, Nakakubo S, Kamada K, Konno S, Teshima T, Kosaki K: “Multiple introductions of SARS-CoV-2 B.1.1.214 lineages from mainland Japan preceded the third wave of the COVID-19 epidemic in Hokkaido”, Travel Med Infect Dis, 22;44:102210.(2021) PubMedへ
  43. Shoji T, Niida Y, Osawa T, Matsumoto R, Sakurai K, Suzuki M, Matsuno Y, Konno S: “Resolution of multifocal micronodular pneumocyte hyperplasia with everolimus in a patient with tuberous sclerosis complex”, Respir Med Case Rep, 34:101526(2021) PubMedへ
  44. Sugimori H, Shimizu K, Makita H, Suzuki M, Konno S: “A Comparative Evaluation of Computed Tomography Images for the Classification of Spirometric Severity of the Chronic Obstructive Pulmonary Disease with Deep Learning”, Diagnostics (Basel) , 11(6):929(2021) PubMedへ
  45. Suzuki M, Cole JJ, Konno S , Makita H, Kimura H, Nishimura M, Maciewicz RA: “Large-scale plasma proteomics can reveal distinct endotypes in chronic obstructive pulmonary disease and severe asthma”, Clin Transl Allergy , 11(10):e12091(2021) PubMedへ
  46. Takagi H, Zhao S, Muto S, Yokouchi H, Nishihara H, Harada T, Yamaguchi H, Mine H, Watanabe M, Ozaki Y, Inoue T, Yamaura T, Fukuhara M, Okabe N, Matsumura Y, Hasegawa T, Osugi J, Hoshino M, Higuchi M, Shio Y, Kanno R, Aoki M, Tan C, Shimoyama S, Yamazaki S, Kikuchi H, Sakakibara-Konishi J, Oizumi S, Harada M, Akie K, Sugaya F, Fujita Y, Takamura K, Kojima T, Honjo O, Minami Y, Nishimura M, Dosaka-Akita H, Nakamura K, Inano A, Isobe H, Suzuki H: “Delta-like 1 homolog (DLK1) as a possible therapeutic target and its application to radioimmunotherapy using 125I-labelled anti-DLK1 antibody in lung cancer models (HOT1801 and FIGHT004)”, Lung cancer, 153:134-142(2021) PubMedへ
  47. Takebayashi T, Taguri M, Odajima H, Hasegawa S, Asakura K, Milojevic A, Takeuchi A, Konno S, Morikawa M, Tsukahara T, Ueda K, Mukai Y, Minami M, Nishiwaki Y, Yoshimura T, Nishimura M, Nitta H: “Exposure to PM2.5 and Lung Function Growth in Pre- and Early Adolescent Schoolchildren”, Ann Am Thorac Soc, 19(5):763-772(2021) PubMedへ
  48. Takei N, Suzuki M, Tanabe N, Oguma A, Shimizu K, Kimura H, Makita H, Sato S, Hirai T, Yokota I, Konno S, Nishimura M: “ Combined assessment of pulmonary arterial enlargement and coronary calcification predicts the prognosis of patients with chronic obstructive pulmonary disease ”, Respir Med, 185:106520 (2021)PubMedへ
  49. Taki K, Yokota I, Fukumoto T, Iwasaki S, Fujisawa S, Takahashi M, Negishi S, Hayasaka K, Sato K, Oguri S, Nishida M, Sugita J, Konno S, Saito T, Teshima T: “SARS-CoV-2 detection by fluorescence loop-mediated isothermal amplification with and without RNA extraction”, J Infect Chemother, (2):410-412(2021) PubMedへ
  50. Tamura Y, Kumamaru H, Abe K, Satoh T, Miyata H, Ogawa A, Tanabe N, Hatano M, Yao A, Tsujino I, Fukuda K, Kimura H, Kuwana M, Matsubara H, Tatsumi K; Japan Pulmonary Hypertension Registry (JAPHR) Network: “Improvements in French risk stratification score were correlated with reductions in mean pulmonary artery pressure in pulmonary arterial hypertension: a subanalysis of the Japan Pulmonary Hypertension Registry (JAPHR)”, BMC PulmMed, ;21(1):28(2021) PubMedへ
  51. Tanabe N, Shimizu K, Terada K, Sato S, Suzuki M, Shima H, Oguma A, Oguma T, Konno S, Nishimura M, Hirai T: “Central airway and peripheral lung structures in airway disease-dominant COPD”, ERJ Open Res, 7(1): 00672-2020(2021) PubMedへ
  52. Tanabe N, Kumamaru H, Tamura Y, Taniguchi H, Emoto N, Yamada Y, Nishiyama O, Tsujino I, Kuraishi H, Nishimura Y, Kimura H, Inoue Y, Morio Y, Nakatsumi Y, Satoh T, Hanaoka M, Kusaka K, Sumitani M, Handa T, Sakao S, Kimura T, Kondoh Y, Nakayama K, Tanaka K, Ohira H, Nishimura M, Miyata H, Tatsumi K; JRPHS Group: “Multi-Institutional Prospective Cohort Study of Patients With Pulmonary Hypertension Associated With Respiratory Diseases”, Circ J, 85(4):333-342(2021) PubMedへ
  53. Tanaka K, Asahina H, Kishimoto J, Miyata Y, Uchida T, Watanabe K, Hamai K, Harada T, Tsubata Y, Sugawara S, Kobayashi K, Sugio K, Oizumi S, Okamoto I: “ Osimertinib versus osimertinib plus chemotherapy for non-small cell lung cancer with EGFR (T790M)-associated resistance to initial EGFR inhibitor treatment: An open-label, randomised phase 2 clinical trial”, Eur J Cancer, 149:14-22(2021) PubMedへ
  54. Yamamoto G, Asahina H, Honjo O, Sumi T, Nakamura A, Ito K, Kikuchi H, Hommura F, Honda R, Yokoo K, Fujita Y, Oizumi S, Morita R, Ikezawa Y, Tanaka H, Kimura N, Sasaki T, Sukoh N, Takashina T, Harada T, Dosaka-Akita H, Isobe H; Hokkaido Lung Cancer Clinical Study Group Trial: “First-line osimertinib in elderly patients with epidermal growth factor receptor-mutated advanced non-small cell lung cancer: a retrospective multicenter study (HOT2002)”, Sci Rep, 11(1):23140(2021) PubMedへ
  55. Yamamoto M, Konno S, Makita H, Nitta K, Shimizu K, Suzuki M, Nishida M, Sugita J, Teshima T , Nishimura M: “Factors for the Variability of Three Acceptable Maximal Expiratory Flow-Volume Curves in Chronic Obstructive Pulmonary Disease”, Int J Chron Obstruct Pulmon Dis, 16:415-422(2021) PubMedへ
  56. Yamashita Y, Maruyama Y, Satokawa H, Nishimoto Y, Tsujino I, Sakashita H, Nakata H, Okuno Y, Ogihara Y, Yachi S, Toya N, Shingaki M, Ikeda S, Yamamoto N, Aikawa S, Ikeda N, Hayashi H, Ishiguro S, Iwata E, Umetsu M, Kondo A, Iwai T, Kobayashi T, Mo M, Yamada N; Taskforce of VTE and COVID-19 in Japan Study: “ Incidence and Clinical Features of Venous Thromboembolism in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) in Japan”, Circ J, 85(12):2208-2214(2021) PubMedへ
  57. Yasuda H, Ichihara E, Sakakibara-Konishi J, Zenke Y, Takeuchi S, Morise M, Hotta K, Sato M, Matsumoto S, Tanimoto A, Matsuzawa R, Kiura K, Takashima Y, Yano S, Koyama J, Fukushima T, Hamamoto J, Terai H, Ikemura S, Takemura R, Goto K, Soejima K: “A phase I/II study of osimertinib in EGFR exon 20 insertion mutation-positive non-small cell lung cancer”, Lung Cancer,162:140-146(2021) PubMedへ
  58. Yokota I, Hattori T, Shane PY, Konno S, Nagasaka A, Takeyabu K, Fujisawa S, Nishida M, Teshima T: “Equivalent SARS-CoV-2 viral loads by PCR between nasopharyngeal swab and saliva in symptomatic patients”, Sci Rep, 11(1):4500 (2021) PubMedへ
  59. Yokota I, Sakurazawa T, Sugita J, Iwasaki S, Yasuda K, Yamashita N, Fujisawa S, Nishida M, Konno S, Teshima T: “Performance of Qualitative and Quantitative Antigen Tests for SARS-CoV-2 Using Saliva”, Infect Dis Rep, 13(3):742-747（2021） PubMedへ
  60. Watanabe K, Toi Y, Nakamura A, Chiba R , Akiyama M, Sakakibara-Konishi J, Tanaka H, Yoshimura N, Miyauchi E, Nakagawa T, Igusa R, Minemura H, Mori Y, Fujimoto K, Matsushita H, Takahashi F, Fukuhara T, Inoue A, Sugawara S, Maemondo M: “Randomized phase II trial of uracil/tegafur and cisplatin versus pemetrexed and cisplatin with concurrent thoracic radiotherapy for locally advanced unresectable stage III non-squamous non-small cell lung cancer: NJLCG1001”, Transl Lung Cancer Res,10(2):712-722(2021) PubMedへ
  61. 阿部結希，清水薫子，中司展人，船木典子 長堀紀子，菅原 満 澁谷 斉，高橋久美子，北川善政，今野 哲，渥美達也：「北海道大学病院における新型コロナウイルス感染症の流行に伴う職務上の影響にかかわる調査結果」，『日本医師会雑誌』，150(1)：95-100（2021）
症例報告
  1. Ito S, Asahina H, Yamaguchi N, Tomaru U, Hasegawa T, Hatanaka Y, Kanako C. Hatanaka-C K, Taguchi H, T Harada T, Ohira H, Ikeda D, Mizugaki H, Kikuchi E, Kikuchi J, Sakakibara-Konishi J, Shinagawa N, and Konno S: “A case of radio-insensitive SMARCA4-deficient thoracic undifferentiated carcinoma with severe right heart failure”, Respir Med Case Rep, 32:101364(2021) PubMedへ
  2. Iwami K, Nakamichi K, Matsushima M, Nagai A, Shirai S, Nakakubo S, Takahashi-Iwata I, Yamada M, Yabe I: “Progressive multifocal leukoencephalopathy with mild clinical conditions and detection of archetype-like JC virus in cerebrospinal fluid”, J Neurovirol, 27(6):917-922(2021) PubMedへ
  3. Kojima Y, Takeyabu K, Kimura M, Matunaga A Kudou J, Ohata Y, Satoh M, Tobioka H, Ishikawa K, Kawamura T: “Case report: Postoperative abdominal recurrence of pulmonary pleomorphic carcinoma showed a dramatic response to S-1 after pembrolizumab”, Respir Med Case Rep, 34:101501（2021） PubMedへ
  4. Kojima Y, Takeyabu K, Kimura M, Matunaga A, Arisato H, Ohata Y, Satoh M: “Tracheomalacia”, QJM, 114(9):673-674(2021) PubMedへ
  5. Nakaya T, Tsujino I, Nakamura J, Chiba Y, Iwano H: “Right ventricular pressure-volume loop produced with simultaneous application of three-dimensional echocardiography and high-fidelity micromanometry in a patient with pulmonary arterial hypertension”, Echocardiography, 38(5):805-807(2021) PubMedへ
  6. Ohara A, Konno S, Shimizu K, Suzuki M, Yamamoto M, Mitani A, Nishida M, Teshima T, Nishimura M: “Two cases of chronic obstructive pulmonary disease with undetectable diffusing capacity for carbon monoxide”, Respir Investig, 59(1):145-148(2021) PubMedへ
  7. Ohe M, Furuya K, Goudarzi H: “Multidrug treatment for COVID-19”, Drug Discov Ther, 15:39-41(2021) PubMedへ
  8. Ohe M, Furuya K, Goudarzi H: “Tetracycline plus macrolide: A potential therapeutic regimen for COVID-19?”, Biosci Trends, 14:467-468(2021) PubMedへ
  9. Omotehara S, Nishida M, Yamanashi K, Sakurai K, Katsurada T, Komatsu Y, Shimizu A, Shibuya H, Shinagawa N, Sugita J, Teshima T: “A case of immune checkpoint inhibitor-associated gastroenteritis detected by ultrasonography”, J Clin Ultrasound, 49(6):605-609(2021) PubMedへ
  10. Otsuka S, Kato T, Ujiie H, Fujiwara-Kuroda A, Hida Y, Kaga K, Wakasa S, Takashima Y, Shinagawa N: “Surgical treatment for tracheal stent prolapse in a patient with blunt tracheal trauma”, Gen Thorac Cardiovasc Surg, 69(12):1589-1592(2021) PubMedへ
  11. Shoji T, Niida Y, Osawa T, Matsumoto R, Sakurai K, Suzuki M, Matsuno Y, Konno S: “Resolution of multifocal micronodular pneumocyte hyperplasia with everolimus in a patient with tuberous sclerosis complex”, Respir Med Case Rep, 34:101526(2021) PubMedへ
  12. Sugiyama M, Hirabayashi S, Ishi Y, Kikuchi J, Ishikura A, Motegi H, Ueda Y, Sawai S, Hara K, Terashita Y, Cho Y, Takakuwa E, Honda S, Yamaguchi S, Kinoshita I, Manabe A: “Notable therapeutic response in a patient with systemic juvenile xanthogranuloma with KIF5B-ALK fusion”, Pediatric Blood & Cancer,68(11): e29227(2021) PubMedへ
  13. Youh J, Imafuku K, Yanagi T, Nakakubo S, Mai Y, Kosumi H, Kawamura T, Muramatsu K, Shiiya C, Kimura A, Itamoto S, Yamada M, Ujiie H: “Macrolide/fluoroquinolone-resistant Campylobacter jejuni-induced cellulitis in a patient with X-linked agammaglobulinaemia successfully treated with carbapenem”, Dermatol Ther, 34(6): e15176(2021) PubMedへ
  14. Yuno A, Kenmotsu Y, Takahashi Y, Nomoto H, Kameda H, Cho KY, Nakamura A, Yamashita Y, Nakamura J, Nakakubo S, Kamada K, Suzuki M, Sugino H, Inoshita N, Konno S, Miyoshi H, Atsumi T, Sawamura Y, Shimatsu A: “Successful management of a patient with active Cushing's disease complicated with coronavirus disease 2019 (COVID-19) pneumonia”, Endocr J, 68(4):477-484(2021) PubMedへ
  15. 児島裕一，竹薮公洋，大畑善寛，佐藤未来，飛岡弘敏，石川慶大，川村　健：「原発性肺癌を合併した肺tumorletの2例」，『肺癌』，61(7):959-963(2021)
  16. 佐々木真知子，清水薫子，鈴木正宣，鈴木 雅，中丸裕爾，今野 哲：「4剤の生物学的製剤を使用し上下気道の反応性の違いを観察し得た重症喘息の1例」，『アレルギー』，70(4):315-320(2021)
  17. 佐藤祐麻，河井康孝，一戸有里香，池澤靖元，木内隆之：「EGFR exon 20 挿入変異陽性肺多形癌にオシメルチニブを導入した1 例」，『肺癌』，61(5):412-416(2021)
総説・解説・その他
  1. Kamada K, Mitarai S: “Anti-Mycobacterial Drug Resistance in japan: How to Approach This Problem?”, Antibiotics, 11(1):19(2021)
  2. 品川尚文，浅野文祐，今林 達哉，沖 昌英，栗本典昭，中島崇裕，西井洋一，丹羽 崇，姫路大輔，松元祐司：「クライオ生検指針　安全にクライオ生検を行うために」，『気管支学』，43(4):355-364(2021)
  3. 品川尚文：「【エキスパートが教える呼吸器内視鏡診療-実地臨床で役立つ秘訣】気管支鏡診断　仮想気管支鏡ナビゲーション(VBN)の実際と問題点」、『呼吸器ジャーナル』，69(2):226-233(2021)